A large-scale organoid-based screening platform to advance drug repurposing in pancreatic cancer
Hirt et al.1 report an automated, high-throughput drug screening platform for organoid cultures to enable repurposing of previously approved drugs for pancreatic cancers harboring specific genetic alterations. The pancreatic cancer organoid biobank also represents a valuable tool to uncover new drug...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-02-01
|
| Series: | Cell Genomics |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666979X22000179 |